-
Pleural mesothelioma incidence and use of systemic treatment decreased during the COVID-19 pandemic in The Netherlands
Smesseim, I., Douma, L.-A. H., Burgers, J. A. & Damhuis, R. A. M., 1 Dec 2025, In: Scientific reports. 15, 1, 25677.Research output: Contribution to journal › Article* › Academic › peer-review
-
Retreatment With Nivolumab and Ipilimumab in Pleural Mesothelioma Following Disease Progression After a Durable Response: Case Series
Smesseim, I., Baas, P. & Burgers, J. A., 1 Jul 2025, In: JTO Clinical and Research Reports. 6, 7, 100835.Research output: Contribution to journal › Article* › Academic › peer-review
-
Follow-up after first-Line nivOlumab plus ipilimumab in patients with diffuse pleuRal mesotheliomA: a real-world Dutch cohort study—FLORA
Douma, L. H., Hofman, M. M., Zwierenga, F., Zondervan, T. M. T., Buma, A. I. G., Schouwink, H., Dumoulin, D. W., Burgers, J. A., Smesseim, I., Aerts, J. G. J. V. & de Gooijer, C. J., 1 Feb 2025, In: ESMO open. 10, 2, 104123.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
